141 results
S-1
INVA
Innoviva Inc
21 Mar 00
IPO registration
12:00am
research
efforts into other significant therapeutic areas.
We expect that a variety of important new drug targets for chronic diseases
such as cancer … , inflammation, and central nervous system disorders will emerge
from biomedical research. We expect that the majority of these targets will be
enzymes
8-K
INVA
Innoviva Inc
14 Dec 20
Entry into a Material Definitive Agreement
6:05am
potential transaction targets; (iv) assist in due diligence of transaction targets and the negotiation and execution of transactions; (v) advise … ) identify potential transaction targets; (iv) assist in due diligence of transaction targets and the negotiation and execution of transactions; (v) advise
8-K
EX-99
INVA
Innoviva Inc
8 Nov 05
Entry into a Material Definitive Agreement
12:00am
by Theravance that targets serious Gram-positive infections including drug-resistant Staphylococcus aureus strains. Previously presented data … . By leveraging its proprietary insight of multivalency to drug discovery focused on validated targets, Theravance is pursuing a next generation drug
8-K
EX-99
INVA
Innoviva Inc
18 Jul 06
Entry into a Material Definitive Agreement
12:00am
to this potential medicine.
Telavancin is a novel lipoglycopeptide injectable antibiotic discovered by Theravance that targets serious Gram-positive infections … with GlaxoSmithKline. By leveraging its proprietary insight of multivalency to drug discovery focused on validated targets, Theravance is pursuing a next
8-K
EX-99
v67sfwiac7 o4568h
29 Jun 07
Other Events
12:00am
8-K
EX-99
z3flz70jaor x3veb6
12 Dec 05
Departure of Directors or Principal Officers
12:00am
SC TO-T/A
EX-99
hc1 ljh2eq6yolhp8
13 Sep 07
Third party tender offer statement (amended)
12:00am
8-K
EX-99.2
sjnyz0 5p0y0wt
23 Jan 08
Theravance Announces Pricing of Convertible Subordinated
12:00am
SC TO-I/A
EX-99
mpnjp66 ql5i
13 Sep 07
Issuer tender offer statement (amended)
12:00am
8-K
EX-99
e65d3
8 Dec 06
Other Events
12:00am
8-K
EX-99
s53nn
5 Mar 08
Other Events
12:00am
8-K
EX-99
rcqhsx3tteqs76l0065
3 Mar 08
Other Events
12:00am
8-K
EX-99.1
ned07cf
11 Jan 06
Theravance Updates Guidance for Initiation of Phase 2b in the LABA Collaboration
12:00am
8-K
EX-99
gd0k6 xomf4u
16 Oct 12
Other Events
12:00am